Advanced search
Publication Cover
Leukemia & Lymphoma Volume 54, 2013 - Issue 2
Submit an article Journal homepage
602
Views
35
CrossRef citations to date
0
Altmetric
Research Article

Clinically meaningful reduction in pruritus in patients with cutaneous T-cell lymphoma treated with romidepsin

Youn H. KimStanford Cancer Center, Stanford, CA, USACorrespondence[email protected]
,
Marie-France DemierreBoston Medical Center, Boston, MA, USA
,
Ellen J. KimUniversity of Pennsylvania, Philadelphia, PA, USA
,
Adam LernerBoston Medical Center, Boston, MA, USA
,
Alain H. RookUniversity of Pennsylvania, Philadelphia, PA, USA
,
Madeleine DuvicMD Anderson Cancer Center, Houston, TX, USA
,
Tadeusz RobakMedical University of Lodz, Lodz, Poland
,
Alexey SamtsovState Educational Institution for Higher Professional Education Military Medical Academy, Saint Petersburg, Russia
,
William McCullochAlba BioPharm Advisors Inc., Raleigh, NC, USA
,
Suephy C. ChenVA Medical Center, Decatur, GA and Emory University, Atlanta, GA, USA
,
Joel WaksmanBrightech International LLC, Somerset, NJ, USA
,
Jean NicholsCelgene Corporation, Summit, NJ, USA
&
Sean WhittakerGuy's and St Thomas’ Hospitals, London, UK
 show all
Pages 284-289 | Received 28 Mar 2012, Accepted 08 Jul 2012, Published online: 17 Aug 2012

Citations (35)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (8)

Madeleine Duvic, Susan E. Bates, Richard Piekarz, Robin Eisch, Youn H. Kim, Adam Lerner, Tadeusz Robak, Alexey Samtsov, Jürgen C. Becker, William McCulloch, Joel Waksman & Sean Whittaker. (2018) Responses to romidepsin in patients with cutaneous T-cell lymphoma and prior treatment with systemic chemotherapy. Leukemia & Lymphoma 59:4, pages 880-887.
Read now
Suzanne van Santen, Maarten H. Vermeer & Rein Willemze. (2018) Classification and recommended treatment options for folliculotropic mycosis fungoides. Expert Opinion on Orphan Drugs 6:1, pages 35-45.
Read now
Piotr Smolewski & Tadeusz Robak. (2017) The discovery and development of romidepsin for the treatment of T-cell lymphoma. Expert Opinion on Drug Discovery 12:8, pages 859-873.
Read now
Alison J. Moskowitz & Steven M. Horwitz. (2017) Targeting histone deacetylases in T-cell lymphoma. Leukemia & Lymphoma 58:6, pages 1306-1319.
Read now
Adam Petrich & Chadi Nabhan. (2016) Use of class I histone deacetylase inhibitor romidepsin in combination regimens. Leukemia & Lymphoma 57:8, pages 1755-1765.
Read now
Ellen J. Kim, Youn H. Kim, Alain H. Rook, Adam Lerner, Madeleine Duvic, Sunil Reddy, Tadeusz Robak, Jürgen C. Becker, Alexey Samtsov, William McCulloch, Joel Waksman & Sean Whittaker. (2015) Clinically significant responses achieved with romidepsin across disease compartments in patients with cutaneous T-cell lymphoma. Leukemia & Lymphoma 56:10, pages 2847-2854.
Read now
Jason B Kaplan, Joan Guitart & Francis J Giles. (2014) Targeted therapies for cutaneous T-cell lymphomas. Expert Review of Hematology 7:4, pages 481-493.
Read now
Emmanuella Guenova, Wolfram Hoetzenecker, Sima Rozati, Mitchell P Levesque, Reinhard Dummer & Antonio Cozzio. (2014) Novel therapies for cutaneous T-cell lymphoma: what does the future hold?. Expert Opinion on Investigational Drugs 23:4, pages 457-467.
Read now

Articles from other publishers (27)

Georgia Biazus Soares, Joan Guitart & Gil Yosipovitch. (2023) What’s New in Cutaneous T-Cell Lymphoma-Associated Pruritus. American Journal of Clinical Dermatology.
Crossref
Jiaxin Liu, Jia-nan Li, Hongyu Wu & Panpan Liu. (2022) The Status and Prospects of Epigenetics in the Treatment of Lymphoma. Frontiers in Oncology 12.
Crossref
Youn H. Kim. (2021) What factors guide treatment selection in mycosis fungoides and Sezary syndrome?. Hematology 2021:1, pages 303-312.
Crossref
Reinhard Dummer, Maarten H. Vermeer, Julia J. Scarisbrick, Youn H. Kim, Connor Stonesifer, Cornelis P. Tensen, Larisa J. Geskin, Pietro Quaglino & Egle Ramelyte. (2021) Cutaneous T cell lymphoma. Nature Reviews Disease Primers 7:1.
Crossref
Georgia Farrah, Odette Spruijt, Chris McCormack, Odette Buelens, Smaro Lazarakis & Miles Prince. (2021) A systematic review on the management of pruritus in patients with cutaneous T-cell lymphoma. Itch 6:2, pages e55-e55.
Crossref
Katarzyna Iżykowska, Karolina Rassek, Dorota Korsak & Grzegorz K. Przybylski. (2020) Novel targeted therapies of T cell lymphomas. Journal of Hematology & Oncology 13:1.
Crossref
Belinda A. Campbell, Julia J. Scarisbrick, Youn H. Kim, Ryan A. Wilcox, Christopher McCormack & H. Miles Prince. (2020) Time to Next Treatment as a Meaningful Endpoint for Trials of Primary Cutaneous Lymphoma. Cancers 12:8, pages 2311.
Crossref
Miriam Rosás-Umbert, Marta Ruiz-Riol, Marco A. Fernández, Marta Marszalek, Pep Coll, Christian Manzardo, Samandhy Cedeño, José M. Miró, Bonaventura Clotet, Tomáš Hanke, José Moltó, Beatriz Mothe & Christian Brander. (2020) In vivo Effects of Romidepsin on T-Cell Activation, Apoptosis and Function in the BCN02 HIV-1 Kick&Kill Clinical Trial. Frontiers in Immunology 11.
Crossref
Thevaki Wain, Victoria L Venning, Germana Consuegra, Pablo Fernandez‐Peñas & Jillian Wells. (2019) Management of cutaneous T‐cell lymphomas: Established and emergent therapies. Australasian Journal of Dermatology 60:3, pages 200-208.
Crossref
Tomonori Oka & Tomomitsu Miyagaki. (2019) Novel and Future Therapeutic Drugs for Advanced Mycosis Fungoides and Sézary Syndrome. Frontiers in Medicine 6.
Crossref
Y. R. Semenov, A. R. Rosenberg, C. Herbosa, N. Mehta‐Shah & A. C. Musiek. (2019) Health‐related quality of life and economic implications of cutaneous T‐cell lymphoma. British Journal of Dermatology.
Crossref
Brian Poligone, Belen Rubio‐Gonzalez & Christiane Querfeld. (2019) Relief of intractable pruritus with romidepsin in patients with cutaneous T ‐ cell lymphoma: A series of four cases . Dermatologic Therapy 32:2, pages e12804.
Crossref
Adriana T. Lopez, Susan Bates & Larisa Geskin. (2018) Current Status of HDAC Inhibitors in Cutaneous T-cell Lymphoma. American Journal of Clinical Dermatology 19:6, pages 805-819.
Crossref
D.J. Lewis, S. Huang & M. Duvic. (2018) Inflammatory cytokines and peripheral mediators in the pathophysiology of pruritus in cutaneous T-cell lymphoma. Journal of the European Academy of Dermatology and Venereology 32:10, pages 1652-1656.
Crossref
Linda Serrano, Maria Estela Martinez-Escala, Xiaolong A. Zhou & Joan Guitart. (2018) Pruritus in Cutaneous T-Cell Lymphoma and Its Management. Dermatologic Clinics 36:3, pages 245-258.
Crossref
Kazuyasu Fujii. (2018) New Therapies and Immunological Findings in Cutaneous T-Cell Lymphoma. Frontiers in Oncology 8.
Crossref
Catherine G. Chung, Brian Poligone & Peter W. Heald. 2018. Biologic and Systemic Agents in Dermatology. Biologic and Systemic Agents in Dermatology 331 342 .
Halle Field, Ling Gao, Pooja Motwani & Henry K. Wong. (2016) Pruritus Reduction with Systemic Anti-lymphoma Treatments in Patients with Cutaneous T Cell Lymphoma: A Narrative Review. Dermatology and Therapy 6:4, pages 579-595.
Crossref
Francine Foss, Madeleine Duvic, Adam Lerner, Joel Waksman & Sean Whittaker. (2016) Clinical Efficacy of Romidepsin in Tumor Stage and Folliculotropic Mycosis Fungoides. Clinical Lymphoma Myeloma and Leukemia 16:11, pages 637-643.
Crossref
Sunil A. Reddy. (2016) Romidepsin for the treatment of relapsed/refractory cutaneous T-cell lymphoma (mycosis fungoides/Sézary syndrome): Use in a community setting. Critical Reviews in Oncology/Hematology 106, pages 99-107.
Crossref
Hiroyuki Murota & Ichiro Katayama. 2016. Pruritus. Pruritus 209 214 .
Catherine G. Chung & Brian Poligone. (2015) Cutaneous T cell Lymphoma: an Update on Pathogenesis and Systemic Therapy. Current Hematologic Malignancy Reports 10:4, pages 468-476.
Crossref
B. Poligone & C. Querfeld. (2015) Management of advanced cutaneous T-cell lymphoma: role of the dermatologist in the multidisciplinary team. British Journal of Dermatology 173:4, pages 1081-1083.
Crossref
Leila Haery, Ryan C. Thompson & Thomas D. Gilmore. (2015) Histone acetyltransferases and histone deacetylases in B- and T-cell development, physiology and malignancy. Genes & Cancer 6:5-6, pages 184-213.
Crossref
Filiberto Cedeno-Laurent, Elisha M. Singer, Maria Wysocka, Bernice M. Benoit, Carmela C. Vittorio, Ellen J. Kim, Gil Yosipovitch & Alain H. Rook. (2015) Improved pruritus correlates with lower levels of IL-31 in CTCL patients under different therapeutic modalities. Clinical Immunology 158:1, pages 1-7.
Crossref
Sarah I. Jawed, Patricia L. Myskowski, Steven Horwitz, Alison Moskowitz & Christiane Querfeld. (2014) Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome). Journal of the American Academy of Dermatology 70:2, pages 223.e1-223.e17.
Crossref
H Miles PrinceMichael Dickinson & Amit Khot. (2013) Romidepsin for cutaneous T-cell lymphoma. Future Oncology 9:12, pages 1819-1827.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.